Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

OU Health marked a significant breakthrough for Oklahoma in lung cancer treatment, becoming the first health care system in ...

Medically reviewed by Susan Russell, MDLung cancer prognosis tends to be better for people diagnosed in earlier stages of the ...

Scientists Discover That Special Immune Cells Stop Metastatic Cancer Oct ... Researchers have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies ...

During a Case-Based Roundtable® event, Patrick M. Forde, MD, discussed safety and tolerability concerns with immunotherapy in ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

It’s possible to catch a cold or get the flu at any time of year. But the chances of becoming sick increase during cold and ...

With lung cancer claiming around 1.8 million lives each year ... Researchers wanted to assess whether physical function was associated with better treatment outcomes in people with metastatic NSCLC.

During a Case-Based Roundtable® event, Chul Kim, MD, discussed the ALTA-1 trial and BRIGHTSTAR trials of brigatinib in ALK+ ...

When treating brain metastases in patients with non–small cell lung cancer (NSCLC), brain radiotherapy has been ... outcomes don’t differ much based on sequencing as long as both treatments are given, ...